Fluoxetine effects on serotonin function and aggressive behavior

Annals of the New York Academy of Sciences

Volumn 794, Issue , 1996, Pages 90-97

  Fuller, Ray W ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN;

AGGRESSION; ANGER; ANTISOCIAL BEHAVIOR; CONFERENCE PAPER; HOSTILITY; HUMAN; NONHUMAN; RAT; SEROTONIN UPTAKE; SEROTONINERGIC NERVE;

ANIMALIA;

EID: 0029851736     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb32512.x     Document Type: Conference Paper

References (62)

1. OLIVIER, B., M. TH. TULP & J. MOS. 1991. Serotonergic receptors in anxiety and aggression: Evidence from animal pharmacology. Hum. Psychopharmacol. 6: S73-S78.
2. MICZEK, K. A., E. WEERTS, M. HANEY & J. TIDEY. 1994. Neurobiological mechanisms controlling aggression: Preclinical developments for pharmacotherapeutic interventions. Neurosci. Biobehav. Rev. 18: 97-110.
3. WOOD, A. 1993. Pharmacotherapy of bulimia nervosa - experience with fluoxetine. Int. Clin. Psychopharmacol. 8: 2295-2299.
4. HARRIS, M. G. & P. BENFIELD. 1994. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness. Drugs & Aging 6(1): 64-84.
5. FULTON, B. & D. MCTAVISH. 1995. Fluoxetine - an overview of its pharmacodynamic and pharmacokinetic properties and review of its therapeutic efficacy in obsessive-compulsive disorder. CNS Drugs 3: 305-322.
6. FULLER, R. W., K. W. PERRY & B. B. MOLLOY. 1975. Effect of 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. J. Pharmacol. Exp. Ther. 193: 796-803.
7. WONG, D. T., F. P. BYMASTER, J. S. HORNG & B. B. MOLLOY. 1975. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifiuoromethylphenoxy)-N-methyl-3-phenylpropylamine. J. Pharmacol. Exp. Ther. 193: 804-811.
8. WONG, D. T., F. P. BYMASTER, L. R. REID & P. G. THRELKELD. 1983. Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors. Biochem. Pharmacol. 32: 1287-1293.
9. FULLER, R. W. & D. T. WONG. 1987. Serotonin reuptake blockers in vitro and in vivo. J. Clin. Psychopharmacol. 7: 36S-43S.
10. GEYER, M. A., W. J. DAWSEY & A. J. MANDELL. 1978. Fading: A new cytofluorimetric measure quantifying serotonin in the presence of catecholamines at the cellular level in brain. J. Pharmacol. Exp. Ther. 207: 650-667.
11. MARSDEN, C. A., J. CONTI, E. STROPE, G. CURZON & R. N. ADAMS. 1979. Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanaesthetized rat using in vivo voltammetry. Brain Res. 171: 85-99.
12. GUAN, X. M. & W. J. MCBRIDE. 1988. Fluoxetine increases the extracellular levels of serotonin in the nucleus accumbens. Brain Res. Bull. 21: 43-46.
13. UNGERSTEDT, U. & A. HALLSTROM. 1987. In vivo microdialysis - A new approach to the analysis of neurotransmitters in the brain. Life Sci. 41: 861-864.
14. FULLER, R. W. 1994. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 55: 163-167.
15. RUTTER, J. J. & S. B. AUERBACH. 1993. Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265: 1319-1324.
16. CLEMENS, J. A., B. D. SAWYER & B. CERIMELE. 1977. Further evidence that serotonin is a neurotransmitter involved in the control of prolactin serotonin. Endocrinology 100: 692-698.
17. FULLER, R. W., K. W. PERRY & B. B. MOLLOY. 1974. Effect of an uptake inhibitor of serotonin metabolism in rat brain: Studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140). Life Sci. 15: 1161-1171.
18. FULLER, R. W. & D. T. WONG. 1977. Inhibition of serotonin uptake. Fed. Proc. Fed. Am. Soc. Exp. Biol. 36: 2154-2158.
19. RUTTER, J. J., C. GUNDLAH & S. B. AUERBACH. 1995. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse 20: 225-233.
20. SABOL, K. E., J. B. RICHARDS & L. S. SEIDEN. 1992. Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Res. 585: 421-424.
21. KALEN, P., R. E. STRECKER, E. ROSENGREN & A. BJORKLUND. 1988. Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection. J. Neurochem. 52: 1422-1435.
22. RUTTER, J. J., C. GUNDLAH & S. B. AUERBACH. 1994. Increase in extracellular serotonin produced by uptake inhibitors is enhanced afterchronic treatment with fluoxetine. Neurosci. Lett. 171: 183-186.
23. GREEN, A. R. & D. J. HEAL. 1985. The effects of drugs on serotonin-mediated behavioural models. In Neuropharmacology of Serotonin. A. R. Green, Ed.: 326-365. Oxford University Press. Oxford, England.
24. ORTMAN, R. 1985. The 5-HT syndrome and the drug discrimination paradigm in rats: Application in behavioral studies on the central 5-HT system. Pharmacopsychiatry 18: 198-201.
25. GROWDEN, J. H. 1977. Postural changes, tremor, and myoclonus in the rat immediately following injections of p-chloroamphetamine. Neurology 27: 1074-1077.
26. SLATER, I. H., G. T. JONES & R. A. MOORE. 1978. Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake. Neuropharmacology 17: 383-389.
27. FULLER, R. W., H. D. SNODDY & B. B. MOLLOY. 1976. Pharmacologic evidence for a serotonin neural pathway involved in hypothalamus-pituitary-adrenal function in rats. Life Sci. 19: 337-346.
28. GIBBS, D. M. & W. VALE. 1983. Effect of the serotonin reuptake inhibitor fiuoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood. Brain Res. 280: 176-179.
29. GOUDIE, A. J., E. W. THORNTON & T. J. WHEELER. 1976. Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotonergic inhibition of feeding. J. Pharm. Pharmacol. 28: 318-320.
30. WURTMAN, J. J. & R. J. WURTMAN. 1977. Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats. Science 198: 1178-1180.
31. ROCKMAN, G. E., Z. AMIT, Z. W. BROWN, C. BOURQUE & S.-O. OGREN. 1982. An investigation of the mechanisms of action of 5-hydroxytryptamine in the suppression of ethanol intake. Neuropharmacology 21: 341-347.
32. TÖRK, I. 1990. Anatomy of the serotonergic system. Ann. N.Y. Acad. Sci. 600: 9-35.
33. JACOBS, B. L. & A. C. AZMITIA. 1992. Structure and function of the brain serotonin system. Physiol. Rev. 72: 165-229.
34. OLIVIER, B., J. MOS, J. VAN DER HEYDEN, J. SCHIPPER, M. TULP, B. BERKELMANS & P. BEVAN. 1987. Serotonergic modulation of agonistic behaviour. In Ethopharmacology of agonistic behaviour in animals and humans. B. Olivier, J. Mos & P. F. Brain, Eds.: 162-186. Martinus Nijhoff Publishers. Dordrecht, the Netherlands.
35. EICHELMAN, B. S. 1990. Neurochemical and psychopharmacologic aspects of aggressive behavior. Annu. Rev. Med. 41: 149-158.
36. VIRKKUNEN, M., D. GOLDMAN, D. A. NIELSEN & M. LINNOILA. 1995. Low brain-serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. J. Psychiatry & Neurosci. 20: 271-275.
37. VARTIAINEN, H., J. TIIHONEN, A. PUTKONEN, H. KOPONEN, M. VIRKKUNEN, P. HAKOLA & H. LEHTO. 1995. Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia. Acta Psychiatr. Scand. 91: 348-351.
38. PIHL, R. O., S. N. YOUNG, P. HARDEN, S. PLOTNICK, B. CHAMBERLAIN & F. R. ERVIN. 1995. Acute effect of altered tryptophan levels and alcohol on aggression in normal human males. Psychopharmacology 119: 353-360.
39. SAUDOU, F., D. A. AMARA, A. DIERICH, M. LEMEUR, S. RAMBOZ, L. SEGU, M. C. BUHOT & R. HEN. 1994. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265: 1875-1878.
40. MEHLMAN, P. T., J. D. HIGLEY, I. FAUCHER, A. A. LILLY, D. M. TAUB, J. VICKERS, S. J. SUOMI & M. LINNOILA. 1994. Low CSF 5-HIAA concentrations and severe aggression and impaired impulse control in nonhuman primates. Am. J. Psychiatry 151: 1485-1491.
41. KYES, R. C., M. B. BOTCHIN, J. R. KAPLAN, S. B. MANUCK & J. J. MANN. 1995. Aggression and brain serotonergic responsivity : Response to slides in male macaques. Physiol. Behav. 57: 205-208.
42. GIBBONS, J. L., M. GLUSMAN, G. A. BARR, W. H. BRIDGER & S. F. LEIBOWITZ. 1978. Serotonergic mechanisms in aggression. Soc. Neurosci. Abstr. 4: 493.
43. KOSTOWSKI, W., L. VALZELLI, W. KOZAK & S. BERNASCONI. 1984. Activity of desipramine, fluoxetine and nomifensine on spontaneous and p-CPA-induced muricidal aggression. Pharmacol. Res. Commun. 16: 265-271.
44. STARK, P., R. W. FULLER & D. T. WONG. 1985. The pharmacologic profile of fluoxetine. J. Clin. Psychiatry 46: 7-13.
45. BERZSENYI, P., E. GALATEO & L. VALZELLI. 1983. Fluoxetine activity on muricidal aggression induced in rats by p-chlorophenylalanine. Aggressive Behav. 9: 333-338.
46. MOLINA, V., L. CIESIELSKI, S. GOBAILLE, F. ISEL & P. MANDEL. 1987. Inhibition of mouse killing behavior by serotonin-mimetic drugs: Effects of partial alterations of serotonin neurotransmission. Pharmacol. Biochem. Behav. 27: 123-131.
47. MOLINA, V., S. GOBAILLE & P. MANDEL. 1986. Effects of serotonin-mimetic drugs on mouse-killing behavior. Aggressive Behav. 12: 201-211.
48. DATLA, K. P., S. K. MITRA & S. K. BHATTACHARYA. 1991. Serotonergic modulation of footshock induced aggression in paired rats. Indian J. Exp. Biol. 29: 631-635.
49. FERRIS, C. F. & Y. DELVILLE. 1994. Vasopressin and serotonin interactions in the control of agonistic behavior. Psychoneuroendocrinology 19: 593-601.
50. WAGNER, G. C., H. FISHER, N. POLE, T. BORVE & S. K. JOHNSON. 1993. Effects of monoaminergic agonists on alcohol-induced increases in mouse aggression. J. Stud. Alcohol Suppl. 11: 185-191.
51. RALEIGH, M. J., M. T. MCGUIRE, G. L. BRAMMER, D. B. POLLACK & A. YUWILER. 1991. Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys. Brain Res. 559: 181-190.
52. CHARNEY, D. S., J. H. KRYSTAL, P. L. DELGADO & G. R. HENINGER. 1990. Serotonin-specific drugs for anxiety and depressive disorders. Annu. Rev. Med. 41: 437-446.
53. COCCARO, E. F., J. L. ASTILL, J. L. HERBERT & A. G. SCHUT. 1990. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients [letter]. J. Clin. Psychopharmacol. 10: 373-375.
54. CORNELIUS, J. R., P. H. SOLOFF, J. M. PEREL & R. F. ULRICH. 1990. Fluoxetine trial in borderline personality disorder. Psychopharmacol. Bull. 26: 151-154.
55. MARKOWITZ, P. I. 1992. Effect of fluoxetine on self-injurious behavior in the developmentally disabled: A preliminary study. J. Clin. Psychopharmacol. 12: 27-31.
56. HEILIGENSTEIN, J. H., C. M. BEASLEY JR. & J. H. POTVIN. 1993. Fluoxetine not associated with increased aggression in controlled clinical trials. Int. Clin. Psychopharmacol. 8: 277-280.
57. FAVA, M., J. F. ROSENBAUM, J. A. PAVA, M. K. MCCARTHY, R. J. STEINGARD & E. BOUFFIDES. 1993. Anger attacks in unipolar depression. Part 1: Clinical correlates and response to fluoxetine treatment. Am. J. Psychiatry 150: 1158-1163.
58. SALZMAN, C., A. N. WOLFSON, A. SCHATZBERG, J. LOOPER, R. HENKE, M. ALBANESE, J. SCHWARTZ & E. MIYAWAKI. 1995. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality-disorder. J. Clin. Psychopharmacol. 15: 23-29.
59. DEMBROSKI, T. M., J. M. MACDOUGALL, R. B. WILLIAMS, T. L. HANEY & J. A. BLUMENTHAL. 1985. Components of type A hostility and anger in relationship to angiographic findings. Psychosom. Med. 47: 219-233.
60. SIEGLER, I. C., B. L. PETERSON, J. C. BAREFOOT & R. B. WILLIAMS. 1992. Hostility during late adolescence predicts coronary risk factors at mid-life. Am. J. Epidemiol. 136: 146-154.
61. BAREFOOT, J. C., J. C. PATTERSON, T. L. HANEY, T. G. CAYTON, J. R. HICKMAN, JR. & R. B. WILLIAMS. 1994. Hostility in asymptomatic men with angiographically confirmed coronary artery disease. Am. J. Cardiol. 74: 439-442.
62. WILLIAMS, R. B. & V. A. WILLIAMS. 1993. Anger Kills: Seventeen Strategies for Controlling the Hostility That Can Harm Your Health. Times Books. New York.